SeaStar Medical

Contributing Author

Recent Articles by SeaStar Medical

Sep-29	SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children ICU GlobeNewswire
Sep-24	SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury ICU GlobeNewswire
Sep-23	SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children ICU GlobeNewswire
Sep-04	SeaStar Medical to Participate in the HC Wainwright 27th Annual Global Investment Conference ICU GlobeNewswire
Sep-02	SeaStar Medical Announces Newly Published QUELIMMUNE Health Economic Study Projecting Significantly Reduced Health Care Costs in the Treatment of Pediatric AKI due to Estimated Shorter Hospital Stays and Increased Survival ICU GlobeNewswire
Aug-13	SeaStar Medical Reports Second Quarter 2025 Financial Results and Provides Business Updates ICU GlobeNewswire
Aug-07	SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025 ICU GlobeNewswire
Aug-06	SeaStar Medical Reaches New Enrollment Milestone in NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury (AKI) ICU GlobeNewswire
Jul-31	SeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules ICU GlobeNewswire
Jul-22	SeaStar Medical Reports Positive Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) from the First 20 SAVE Surveillance Registry Patients ICU GlobeNewswire
Jul-16	SeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry ICU GlobeNewswire
Jul-10	SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules ICU GlobeNewswire
Jul-08	SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI) ICU GlobeNewswire
Jul-02	SeaStar Medical Announces Positive Nasdaq Listing Determination ICU GlobeNewswire
Jun-25	SeaStar Medical Reports Update on Nasdaq Listing Status ICU GlobeNewswire
Jun-24	SeaStar Medical Announces Two Feature Stories on QUELIMMUNE Adoption and Patient Testimonial of Life-Saving Therapy ICU GlobeNewswire
Jun-20	SeaStar Medical Announces Pricing of Up to $8 Million Public Offering ICU GlobeNewswire
May-28	SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy ICU GlobeNewswire
May-14	SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates ICU GlobeNewswire
May-13	SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury ICU GlobeNewswire
May-07	SeaStar Medical to Report First Quarter Financial Results on May 14, 2025 ICU GlobeNewswire

SeaStar Medical

Recent Articles by SeaStar Medical

Upgrade your FINVIZ experience